InvestorsHub Logo
Followers 66
Posts 2132
Boards Moderated 0
Alias Born 03/04/2018

Re: abew4me post# 439842

Thursday, 11/23/2023 2:49:56 PM

Thursday, November 23, 2023 2:49:56 PM

Post# of 464008
Abe,

Hey Doc.

I was hoping to get your opinion on the recent PR. Pretty impressive, aye?



I guess you missed my post. I had already offered my opinion a couple hours after the PR in post # 439367

Anavex PR'd that they sent in a request to the EMA asking permission to send in one type of MAA application instead of the default type. There's nothing negative but nothing earth shattering positive either. All biologics and most new drugs that turn in the MAA go through the Centralised Protocol. This is not a material event (try to find another company that PR'd this common event). I would be shocked if the EMA does not honor the request as they do with most drugs. What happens if Anavex receives permission to use the Centralised Protocol and then does not turn in an MAA? Nothing, they can re-apply in a year. And reapply again a year later. And reapply again a year after that... The renewable basis is certainly a positive for Missling. From the guidance "Conditional marketing authorisations will be valid for one year, on a renewable basis. The holder will be required to complete ongoing studies or to conduct new studies (as part of specific obligations) with a view to confirming that the risk-benefit balance is favourable. "

I'll be a little impressed if an MAA is accepted and a lot impressed if the MAA is approved

Off to make the cranberry sauce for the meal - Have a Great Thanksgiving!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News